Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chunjuan Zhai

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Chinese Medical Journal|August 23, 2023
Fixed-effect and random-effects models in meta-analysisChunjuan Zhai, Gordon Guyatt
Advances in Therapy|June 11, 2025
The Effect of Leuprolide Acetate 11.25 mg 3-Month Formulation in Children with Central Precocious Puberty: A Systematic Review and Meta-analysisLinqi Han, Chunjuan Zhai, La Da, et al.
Advances in Therapy|October 8, 2025
Correction to: The Effect of Leuprolide Acetate 11.25 mg 3-Month Formulation in Children with Central Precocious Puberty: A Systematic Review and Meta-analysisLinqi Han, Chunjuan Zhai, La Da, et al.
Postgraduate Medical Journal|April 23, 2024
Umeclidinium plus vilanterol versus fluticasone propionate plus salmeterol for chronic obstructive pulmonary disease: a meta-analysis of randomized, controlled trialsChunjuan Zhai, Fen Wang, Ruie Xu, et al.
Renal Failure|April 5, 2022
Anti-PLA2R antibody measured by ELISA predicts the risk of vein thrombosis in patients with primary membranous nephropathyHuizi Zhu, Liang Xu, Xiang Liu, et al.
Frontiers in Public Health|April 24, 2023
Association between adverse oral conditions and cognitive impairment: A literature reviewTianhao Wei, Yifeng Du, Tingting Hou, et al.
American Journal of Nephrology|March 19, 2025
The Role of Neutrophils in Venous Thrombosis in Primary Membranous NephropathyQiuhan Wang, Benxia Bing, Liang Xu, et al.
Renal Failure|May 15, 2023
Association of circulating proprotein convertase subtilisin/kexin type 9 concentration with coagulation abnormalities in patients with primary membranous nephropathyHuizi Zhu, Qian Meng, Xiang Liu, et al.
Frontiers in Pharmacology|February 12, 2024
Case report: One case of refractory membranous nephropathy with hypokalemia after rituximab infusion was switched to obinutuzumab without recurrence of hypokalemiaYao Zhang, Jing Sun, Jie Gao, et al.
Journal of Cellular and Molecular Medicine|March 9, 2017
TUSC3: a novel tumour suppressor gene and its functional implicationsXinshuang Yu, Chunjuan Zhai, Yujun Fan, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Chinese Medical Journal|August 23, 2023
Fixed-effect and random-effects models in meta-analysisChunjuan Zhai, Gordon Guyatt
Advances in Therapy|June 11, 2025
The Effect of Leuprolide Acetate 11.25 mg 3-Month Formulation in Children with Central Precocious Puberty: A Systematic Review and Meta-analysisLinqi Han, Chunjuan Zhai, La Da, et al.
Advances in Therapy|October 8, 2025
Correction to: The Effect of Leuprolide Acetate 11.25 mg 3-Month Formulation in Children with Central Precocious Puberty: A Systematic Review and Meta-analysisLinqi Han, Chunjuan Zhai, La Da, et al.
Postgraduate Medical Journal|April 23, 2024
Umeclidinium plus vilanterol versus fluticasone propionate plus salmeterol for chronic obstructive pulmonary disease: a meta-analysis of randomized, controlled trialsChunjuan Zhai, Fen Wang, Ruie Xu, et al.
Renal Failure|April 5, 2022
Anti-PLA2R antibody measured by ELISA predicts the risk of vein thrombosis in patients with primary membranous nephropathyHuizi Zhu, Liang Xu, Xiang Liu, et al.
Frontiers in Public Health|April 24, 2023
Association between adverse oral conditions and cognitive impairment: A literature reviewTianhao Wei, Yifeng Du, Tingting Hou, et al.
American Journal of Nephrology|March 19, 2025
The Role of Neutrophils in Venous Thrombosis in Primary Membranous NephropathyQiuhan Wang, Benxia Bing, Liang Xu, et al.
Renal Failure|May 15, 2023
Association of circulating proprotein convertase subtilisin/kexin type 9 concentration with coagulation abnormalities in patients with primary membranous nephropathyHuizi Zhu, Qian Meng, Xiang Liu, et al.
Frontiers in Pharmacology|February 12, 2024
Case report: One case of refractory membranous nephropathy with hypokalemia after rituximab infusion was switched to obinutuzumab without recurrence of hypokalemiaYao Zhang, Jing Sun, Jie Gao, et al.
Journal of Cellular and Molecular Medicine|March 9, 2017
TUSC3: a novel tumour suppressor gene and its functional implicationsXinshuang Yu, Chunjuan Zhai, Yujun Fan, et al.
Pageof 3